Literature DB >> 8549281

Role of quinolones in the treatment of diarrhoeal diseases.

H E Akalin1.   

Abstract

Diarrhoeal diseases are still an important health problem in both developing and developed countries, and resistance to commonly used antibiotics among enteric pathogens is a major issue. Quinolones have become important agents in the treatment of diarrhoeal diseases because of their excellent in vitro activity against pathogens and their pharmacological features. In many clinical studies, they appeared to be effective in the treatment of shigellosis and the prevention and treatment of diarrhoea in travellers. Several studies have demonstrated that single-dose therapy with these agents is sufficient in many cases. Their role in the treatment of acute salmonellosis is still controversial, because of their lack of efficacy in eliminating salmonella from the faeces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549281     DOI: 10.2165/00003495-199500492-00020

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  29 in total

1.  Characterization of high-level quinolone resistance in Campylobacter jejuni.

Authors:  T D Gootz; B A Martin
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess.

Authors:  A P Gibb; C S Lewin; O J Garden
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

3.  Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.

Authors:  L J Goodman; G M Trenholme; R L Kaplan; J Segreti; D Hines; R Petrak; J A Nelson; K W Mayer; W Landau; G W Parkhurst
Journal:  Arch Intern Med       Date:  1990-03

4.  Occurrence of drug resistance in Shigella species isolated from patients with diarrhoea in Bangladesh.

Authors:  K Haider; M A Malek; M J Albert
Journal:  J Antimicrob Chemother       Date:  1993-09       Impact factor: 5.790

5.  Norfloxacin treatment of salmonellosis does not shorten the carrier stage.

Authors:  G Carlstedt; P Dahl; P M Niklasson; K Gullberg; G Banck; G Kahlmeter
Journal:  Scand J Infect Dis       Date:  1990

Review 6.  Quinolones in the treatment of acute bacterial diarrhoeal diseases.

Authors:  H E Akalin
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

Authors:  H E Pichler; G Diridl; K Stickler; D Wolf
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

8.  Diarrheal disease during Operation Desert Shield.

Authors:  K C Hyams; A L Bourgeois; B R Merrell; P Rozmajzl; J Escamilla; S A Thornton; G M Wasserman; A Burke; P Echeverria; K Y Green
Journal:  N Engl J Med       Date:  1991-11-14       Impact factor: 91.245

Review 9.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

10.  High-level quinolone resistance in clinical isolates of Campylobacter jejuni.

Authors:  J Segreti; T D Gootz; L J Goodman; G W Parkhurst; J P Quinn; B A Martin; G M Trenholme
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

View more
  3 in total

1.  In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.

Authors:  Rea Krausse; Uwe Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 2.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

3.  Infectious Enteritis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.